Nika Pharmaceuticals, Inc. (NIKA) Signed a Distribution Agreement for Nigeria
18. Juli 2024 11:35 ET
|
Nika Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA) signed a distribution agreement for the Republic of Nigeria that can generate the company €7.9 billion revenue.
Nika Pharmaceuticals, Inc. (NIKA) Presents Its Business Strategy
03. Juni 2024 10:35 ET
|
Nika Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc. (NIKA) introduces its business strategy that should generate a net profit of more than 1 billion USD by the end of 2025.
Nika Pharmaceuticals, Inc. (NIKA) Acquires a Two Million USD Production Building
10. Mai 2024 13:41 ET
|
Nika Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc. (NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.
Nika Pharmaceuticals, Inc. (Nika) Acquires a Two Million USD Production Building
10. Mai 2024 12:55 ET
|
Nika Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc. (NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.
Nika Pharmaceuticals, Inc. (NKPH) Purchased the Technologies for Three Drugs in Tablet Form and One Dietary Supplement
15. April 2024 09:48 ET
|
Nika Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc. (NKPH) announces the purchase of technologies for production of three generic drugs in tablet form and one dietary supplement.
Nika Pharmaceuticals, Inc. (NKPH) Merges With Nika Biotechnology, Inc.
20. März 2024 14:30 ET
|
Nika Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc. (OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc., effective as of March 1, 2024.